WASHINGTON, Sept. 14 (TNSLrpt) -- The Congressional Budget Office issued the following report on Sept. 9, 2025, entitled "Growth in the 340B Drug Pricing Program." Here are excerpts: * * * At a Glance The 340B Drug Pricing Program requires pharmaceutical manufacturers to sell outpatient prescription drugs to participating health care facilities at discounted prices. Facilities that participate in the 340B program are hospitals, clinics, and other providers of health care services as well as  more PR

WASHINGTON, Sept. 14 (TNSLrpt) -- The Congressional Budget Office issued the following report on Sept. 9, 2025, entitled "Growth in the 340B Drug Pricing Program:" (Continued from Part 1 of 2) * * * Drug Purchases Through the 340B Program in 2021 In 2021, health care facilities that participated in the PVP spent $43.9 billion on drugs purchased through the 340B program. (For details about how CBO measured spending, see Appendix B.) CBO estimates that spending on drugs purchased by facilities more PR

WASHINGTON, Sept. 15 (TNSLrpt) -- The Congressional Research Service issued the following report (No. RS20643) on Aug. 1, 2025, entitled "Navy Ford (CVN-78) Class Aircraft Carrier Program - Background and Issues for Congress:" (Continued from Part 1 of 2) * * * Issues for Congress Cost Growth and Schedule Delays One oversight issue for Congress concerns cost growth and schedule delays in building Ford-class ships. Cost growth in building Ford-class ships is shown in Table 2. As discussed  more PR